Oslo Universitetssykehus-Radiumhospitalet

Oslo, Oslo 0379

1 studies enrolling now · 1 studies all time

What they study most

Cancer Harboring BRAF Alterations, HGG, LGG, Solid Tumors

Studies at this site

• A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations — Recruiting now